Varian Medical Systems (VAR) : Needham Investment Management reduced its stake in Varian Medical Systems by 1.43% during the most recent quarter end. The investment management company now holds a total of 69,000 shares of Varian Medical Systems which is valued at $6,549,480 after selling 1,000 shares in Varian Medical Systems , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.Varian Medical Systems makes up approximately 1.72% of Needham Investment Management’s portfolio.
Other Hedge Funds, Including , Invictus Rg Pte. Ltd. reduced its stake in VAR by selling 2,447 shares or 51.87% in the most recent quarter. The Hedge Fund company now holds 2,271 shares of VAR which is valued at $215,563. Varian Medical Systems makes up approx 0.18% of Invictus Rg Pte. Ltd.’s portfolio.Blackrock Advisors reduced its stake in VAR by selling 9,120 shares or 4.73% in the most recent quarter. The Hedge Fund company now holds 183,837 shares of VAR which is valued at $17,449,808. Varian Medical Systems makes up approx 0.02% of Blackrock Advisors’s portfolio.Bridgewater Associates Lp reduced its stake in VAR by selling 61,843 shares or 58.21% in the most recent quarter. The Hedge Fund company now holds 44,400 shares of VAR which is valued at $4,214,448. Varian Medical Systems makes up approx 0.05% of Bridgewater Associates Lp’s portfolio.First National Bank Of Omaha reduced its stake in VAR by selling 47,003 shares or 93.13% in the most recent quarter. The Hedge Fund company now holds 3,470 shares of VAR which is valued at $302,272. Varian Medical Systems makes up approx 0.02% of First National Bank Of Omaha’s portfolio.First Quadrant L Pca reduced its stake in VAR by selling 187,600 shares or 91.83% in the most recent quarter. The Hedge Fund company now holds 16,700 shares of VAR which is valued at $1,454,737. Varian Medical Systems makes up approx 0.03% of First Quadrant L Pca’s portfolio.
Varian Medical Systems opened for trading at $96.33 and hit $97.45 on the upside on Wednesday, eventually ending the session at $97.27, with a gain of 0.81% or 0.78 points. The heightened volatility saw the trading volume jump to 562,514 shares. Company has a market cap of $9,083 M.
On the company’s financial health, Varian Medical Systems reported $1.22 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $1.17. The company had revenue of $789.40 million for the quarter, compared to analysts expectations of $782.00 million. The company’s revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.15 EPS.
Many Wall Street Analysts have commented on Varian Medical Systems. Company shares were Reiterated by Barrington Research on Jul 28, 2016 to “Outperform”, Firm has raised the Price Target to $ 102 from a previous price target of $93 .
Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy radiosurgery proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical scientific and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer taking X-ray images and protecting ports and borders. The Companys products include linear accelerators brachytherapy afterloaders treatment simulation and verification equipment accessories information management treatment planning and image processing software. The Companys customers include university research and community hospitals private and governmental institutions healthcare agencies doctors offices and cancer care clinics.